Sponsors have increasingly adopted new clinical trial models, including decentralised trials and real-world data, but global regulatory harmonisation has been lacking.

The post ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD appeared first on Clinical Trials Arena.